Rotam Trait Development

Rotam Trait Development is an agricultural trait-development business associated with the Rotam group, focused on financing, developing, licensing, and commercializing crop trait technologies with partners worldwide. Public descriptions of the business center on plant biotechnology rather than human therapeutics, with reported work in gene-edited rice traits conferring tolerance to multiple herbicide classes. The entity appears to have operated through holding and Hong Kong subsidiaries including Rotam Trait Development Holdings Company Limited and Rotam Trait Development (HK) Company Limited. Rotam as a broader corporate group was acquired by Albaugh in May 2022, and Rotam-branded operations continue under Albaugh ownership. Based on available evidence, this is not a life science, biotech-pharma, or healthcare company in the human health sense, but an agbiotech/crop trait company.